Pre-mRNA splicing and human disease

Genes and Development

Volumn 17, Issue 4, 2003, Pages 419-437

  Faustino, Nuno André ^a,b   Cooper, Thomas A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

CHROMOSOME 17; CYSTIC FIBROSIS; EXON; FRASER SYNDROME; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; INTRON; MALIGNANT NEOPLASTIC DISEASE; MYOTONIC DYSTROPHY; NONHUMAN; OPEN READING FRAME; PARKINSON DISEASE; PRIORITY JOURNAL; RETINITIS PIGMENTOSA; REVIEW; RNA SPLICING; SPINAL MUSCULAR ATROPHY;

CYSTIC FIBROSIS; DEMENTIA; DENYS-DRASH SYNDROME; DISEASE; HUMAN GROWTH HORMONE; MUSCULAR ATROPHY, SPINAL; MUTATION; MYOTONIC DYSTROPHY; NEOPLASMS; PARKINSONIAN DISORDERS; RETINITIS PIGMENTOSA; RNA PRECURSORS; RNA SPLICING;

EID: 0037443035     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1048803     Document Type: Review

References (183)

1. Andreassi, C., Jarecki, J., Zhou, J., Coovert, D.D., Monani, U.R., Chen, X., Whitney, M., Pollok, B., Zhang, M., Androphy, E., et al. 2001. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. Hum. Mol. Genet. 10: 2841-2819.
2. Armstrong, J.F., Pritchard-Jones, K., Bickmore, W.A., Hastie, N.D., and Bard, J.B. 1993. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech. Dev. 40:85-97.
3. Artero, R., Prokop, A., Paricio, N., Begemann, G., Pueyo, I., Mlodzik, M., Perez-Alonso, M., and Baylies, M.K. 1998. The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. Dev. Biol. 195: 131-143.
4. Ayadi, L., Callebaut, I., Saguez, C., Villa, T., Mornon, J.P., and Banroques, J. 1998. Functional and structural characterization of the prp3 binding domain of the yeast prp4 splicing factor. J. Mol. Biol. 284: 673-687.
5. Baccon, J., Pellizzoni, L., Rappsilber, J., Mann, M., and Dreyfuss, G. 2002. Identification and characterization of Gemin7, a novel component of the survival of motor neuron complex. J. Biol. Chem. 277: 31957-31962.
6. Barbaux, S., Niaudet, P., Gubler, M.C., Grunfeld, J.P., Jaubert, F., Kuttenn, F., Fekete, C.N., Souleyreau-Therville, N., Thibaud, E., Fellous, M., et al. 1997. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat. Genet. 17: 467-470.
7. 3His-type zinc-finger-containing proteins. Development 124: 4321-4331.
8. Berget, S.M. 1995. Exon recognition in vertebrate splicing. J. Biol. Chem. 270: 2411-2414.
9. Berget, S.M., Moore, C., and Sharp, P.A. 1977. Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. 74: 3171-3175.
10. Bessant, D.A., Ali, R.R., and Bhattacharya, S.S. 2001. Molecular genetics and prospects for therapy of the inherited retinal dystrophies. Curr. Opin. Genet. Dev. 11: 307-316.
11. Binder, G., Brown, M., and Parks, J.S. 1996. Mechanisms responsible for dominant expression of human growth hormone gene mutations. J. Clin. Endocrinol. Metab. 81: 4047-4050.
12. +, that links splicing and meiosis. Nucleic Acids Res. 28: 2214-2220.
13. Black, D.L. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. (In press).
14. Blencowe, B.J. 2000. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25: 106-110.
15. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P.R. 2000. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33: 95-130.
16. Buj-Bello, A., Furling, D., Tronchere, H., Laporte, J., Lerouge, T., Butler-Browne, G.S., and Mandel, J.L. 2002. Muscle-specific alternative splicing of myotubularin- related 1 gene is impaired in DM1 muscle cells. Hum. Mol. Genet. 11: 2297-2307.
17. Buratti, E., Dork, T., Zuccato, E., Pagani, F., Romano, M., and Baralle, F.E. 2001. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20: 1774-1784.
18. Burge, C.B., Tuschl, T., and Sharp, P.A. 1999. Splicing of precursors to mRNAs by the spliceosomes. In The RNA world (eds. R.F. Gesteland et al.), pp. 525-560. Cold Spring Harbor Press, Cold Spring Harbor, NY.
19. Burlet, P., Huber, C., Bertrandy, S., Ludosky, M.A., Zwaenepoel, I., Clermont, O., Roume, J., Delezoide, A.L., Cartaud, J., Munnich, A., et al. 1998. The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum. Mol. Genet. 7: 1927-1933.
20. Burns, C.G., Ohi, R., Mehta, S., O'Toole, E.T., Winey, M., Clark, T.A., Sugnet, C.W., Ares Jr., M., and Gould, K.L. 2002. Removal of a single α-tubulin gene intron suppresses cell cycle arrest phenotypes of splicing factor mutations in Saccharomyces cerevisiae. Mol. Cell. Biol. 22: 801-815.
21. Caceres, J.F. and Komblihtt, A.R. 2002. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet. 18: 186-193.
22. Caceres, J.F., Screaton, G.R., and Krainer, A.R. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes & Dev. 12: 55-66.
23. Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., et al. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
24. Cartegni, L. and Krainer, A.R. 2002. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat. Genet. 30: 377-384.
25. Cartegni, L., Chew, S.L., and Krainer, A.R. 2002. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3: 285-298.
26. Chakarova, C.F., Hims, M.M., Bolz, H., Abu-Safieh, L., Patel, R.J., Papaioannou, M.G., Ingleheam, C.F., Keen, T.J., Willis, C., Moore, A.T., et al. 2002. Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum. Mol. Genet. 11: 87-92.
27. Chalfant, C.E., Ogretmen, B., Galadari, S., Kroesen, B.J., Pettus, B.J., and Hannun, Y.A. 2001. FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1. J. Biol. Chem. 276: 44848-44855.
28. Chalfant, C.E., Rathman, K., Pinkerman, R.L., Wood, R.E., Obeid, L.M., Ogretmen, B., and Hannun, Y.A. 2002. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J. Biol. Chem. 277: 12587-12595.
29. Charlet-B., N., Logan, P., Singh, G., and Cooper, T.A. 2002a. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell 9: 649-658.
30. Charlet-B., N., Savkur, R.S., Singh, G., Philips, A.V., Grice, E.A., and Cooper, T.A. 2002b. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol. Cell 10: 45-53.
31. Chen, E.J., Frand, A.R., Chitouras, E., and Kaiser, C.A. 1998. A link between secretion and pre-mRNA processing defects in Saccharomyces cerevisiae and the identification of a novel splicing gene, RSE1. Mol. Cell. Biol. 18: 7139-7146.
32. Chillon, M., Casals, T., Mercier, B., Bassas, L., Lissens, W., Silber, S., Romey, M.C., Ruiz-Romero, J., Verlingue, C., Claustres, M., et al. 1995. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 332: 1475-1480.
33. Chow, L.T., Gelinas, R.E., Broker, T.R., and Roberts, R.J. 1977. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12: 1-8.
34. Chu, C.S., Trapnell, B.C., Curristin, S.M., Cutting, G.R., and Crystal, R.G. 1992. Extensive posttranscriptional deletion of the coding sequences for part of nucleotide-binding fold 1 in respiratory epithelial mRNA transcripts of the cystic fibrosis transmembrane conductance regulator gene is not associated with the clinical manifestations of cystic fibrosis. J. Clin. Invest. 90: 785-790.
35. Cifuentes-Diaz, C., Frugier, T., Tiziano, F.D., Lacene, E., Roblot, N., Joshi, V., Moreau, M.H., and Melki, J. 2001. Deletion of murine SMN exon 7 directed to skeletal muscle leads to severe muscular dystrophy. J. Cell Biol. 152: 1107-1114.
36. Clark, T.A., Sugnet, C.W., and Ares Jr., M. 2002. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science 296: 907-910.
37. Cogan, J.D., Phillips III, J.A., Schenkman, S.S., Milner, R.D., and Sakati, N. 1994. Familial growth hormone deficiency: A model of dominant and recessive mutations affecting a monomeric protein. J. Clin. Endocrinol. Metab. 79: 1261-1265.
38. Cogan, J.D., Prince, M.A., Lekhakula, S., Bundey, S., Futrakul, A., McCarthy, E.M., and Phillips III, J.A. 1997. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum. Mol. Genet. 6: 909-912.
39. Collins, C.A. and Guthrie, C. 2000. The question remains: Is the spliceosome a ribozyme? Nat. Struct. Biol. 7: 850-854.
40. Cooper, D.N., Krawczak, M., and Antonarakis, S.E. 1995. The nature and mechanisms of human gene mutation. In The metabolic basis of inherited disease (eds. C.R. Scriver et al.), pp. 259-291. McGraw-Hill, New York.
41. Cooper, T.A. and Mattox, W. 1997. The regulation of splice site selection and its role in human disease. Am. J. Hum. Genet. 61:259-266.
42. Coovert, D.D., Le, T.T., McAndrew, P.E., Strasswimmer, J., Crawford, T.O., Mendell, J.R., Coulson, S.E., Androphy, E.J., Prior, T.W., and Burghes, A.H. 1997. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6: 1205-1214.
43. Coulter, L.R., Landree, M.A., and Cooper, T.A. 1997. Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol. 17: 2143-2150.
44. m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Invest. 101: 487-496.
45. Davies, R.C., Calvio, C., Bratt, E., Larsson, S.H., Lamond, A.I., and Hastie, N.D. 1998. WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes. Genes & Dev. 12: 3217-3225.
46. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H., and Housman, D.E. 1997. Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. 94: 7388-7393.
47. Delaney, S.J., Rich, D.P., Thomson, S.A., Hargrave, M.R., Lovelock, P.K., Welsh, M.J., and Wainwright, B.J. 1993. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat. Genet. 4: 426-431.
48. D'Souza, I., Poorkaj, P., Hong, M., Nochlin, D., Lee, V.M., Bird, T.D., and Schellenberg, G.D. 1999. Missense and silent tau gene mutations cause frontotemporal dementia with Parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. Proc. Natl. Acad. Sci. 96: 5598-5603.
49. Du, H. and Rosbash, M. 2002. The U1 snRNP protein U1C recognizes the 5′ splice site in the absence of base pairing. Nature 419: 86-90.
50. Engelbrecht, J., Knudsen, S., and Brunak, S. 1992. G + C-rich tract in 5′ end of human introns. J. Mol. Biol. 227: 108-113.
51. Fackenthal, J.D., Cartegni, L., Krainer, A.R., and Olopade, O.I. 2002. BRCA2 T2722R is a deleterious allele that causes exon skipping. Am. J. Hum. Genet. 71: 625-631.
52. Fairbrother, W.G. and Chasin, L.A. 2000. Human genomic sequences that inhibit splicing. Mol. Cell. Biol. 20: 6816-6825.
53. Fairbrother, W.G., Yeh, R.F., Sharp, P.A., and Burge, C.B. 2002. Predictive identification of exonic splicing enhancers in human genes. Science 297: 1007-1013.
54. Fardaei, M., Larkin, K., Brook, J.D., and Hamshere, M.G. 2001. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res. 29: 2766-2771.
55. Fardaei, M., Rogers, M.T., Thorpe, H.M., Larkin, K., Hamshere, M.G., Harper, P.S., and Brook, J.D. 2002. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum. Mol. Genet. 11: 805-814.
56. Feldkotter, M., Schwarzer, V., Wirth, R., Wienker, T.F., and Wirth, B. 2002. Quantitative analyses of SMN1 and SMN2 based on real-time light cycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am. J. Hum. Genet. 70: 358-368.
57. Gessler, M., Poustka, A., Cavenee, W., Neve, R.L., Orkin, S.H., and Bruns, G.A. 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343: 774-778.
58. Golling, G., Amsterdam, A., Sun, Z., Antonelli, M., Maldonado, E., Chen, W., Burgess, S., Haldi, M., Artzt, K., Farrington, S., et al. 2002. Insertional mutagenesis in zebrafish rapidly identifies genes essential for early vertebrate development. Nat. Genet. 31: 135-140.
59. Gonzalez- Santos, J.M., Wang, A., Jones, J., Ushida, C., Liu, J., and Hu, J. 2002. Central region of the human splicing factor Hprp3p interacts with Hprp4p. J. Biol. Chem. 277: 23764-23772.
60. Good, P.J., Chen, Q., Warner, S.J., and Herring, D.C. 2000. A family of human RNA-binding proteins related to the Drosophila Bruno translational regulator. J. Biol. Chem. 275: 28583-28592.
61. Grabowski, P.J. 1998. Splicing regulation in neurons: Tinkering with cell-specific control. Cell 92: 709-712.
62. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haußmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-25.
63. Guo, Y., Ma, J., Wang, J., Che, X., Narula, J., Bigby, M., Wu, M., and Sy, M.S. 1994. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res. 54: 1561-1565.
64. Haber, D.A., Sohn, R.L., Buckler, A.J., Pelletier, J., Call, K.M., and Housman, D.E. 1991. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc. Natl. Acad. Sci. 88: 9618-9622.
65. Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., Gubler, M.C., and Schedl, A. 2001. Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation. Cell 106: 319-329.
66. Harper, P.S. 2001. Myotonic dystrophy. W.B. Saunders, London.
67. Hastings, M.L. and Krainer, A.R. 2001. Pre-mRNA splicing in the new millennium. Curr. Opin. Cell Biol. 13: 302-309.
68. Hentze, M.W. and Kulozik, A.E. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96: 307-310.
69. Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J., and Wirth, B. 2000. Htra2-β 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl. Acad. Sci. 97: 9618-9623.
70. Hong, M., Zhukareva, V., Vogelsberg-Ragaglia, V., Wszolek, Z., Reed, L., Miller, B.I., Geschwind, D.H., Bird, T.D., McKeel, D., Goate, A., et al. 1998. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282: 1914-1917.
71. Hossain, A. and Saunders, G.F. 2001. The human sex-determining gene SRY is a direct target of WT1. J. Biol. Chem. 276: 16817-16823.
72. Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H., and Li, H. 2000. A mouse model for spinal muscular atrophy. Nat. Genet. 24: 66-70.
73. Hu, G.K., Madore, S.J., Moldover, B., Jatkoe, T., Balaban, D., Thomas, J., and Wang, Y. 2001. Predicting splice variant from DNA chip expression data. Genome Res. 11: 1237-1245.
74. Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. 1998. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702-705.
75. Jablonka, S., Schrank, B., Kralewski, M., Rossoll, W., and Sendtner, M. 2000. Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: An animal model for spinal muscular atrophy type III. Hum. Mol. Genet. 9: 341-346.
76. Jablonka, S., Holtmann, B., Meister, G., Bandilla, M., Rossoll, W., Fischer, U., and Sendtner, M. 2002. Gene targeting of Gemin2 in mice reveals a correlation between defects in the biogenesis of U snRNPs and motoneuron cell death. Proc. Natl. Acad. Sci. 99: 10126-10131.
77. Jensen, K.B., Dredge, B.K., Stefani, G., Zhong, R., Buckanovich, R.J., Okano, H.J., Yang, Y.Y., and Darnell, R.B. 2000. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25: 359-371.
78. Jiang, Z.H. and Wu, J.Y. 1999. Alternative splicing and programmed cell death. Proc. Soc. Exp. Biol. Med. 220: 64-72.
79. Jin, W., Huang, E.S., Bi, W., and Cote, G.J. 1999. Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1 α-exon recognition in glioblastoma cells. J. Biol. Chem. 274: 28035-28041.
80. Jin, W., McCutcheon, I.E., Fuller, G.N., Huang, E.S., and Cote, G.J. 2000. Fibroblast growth factor receptor-1 α-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res. 60: 1221-1224.
81. Kalbfuss, B., Mabon, S.A., and Misteli, T. 2001. Correction of alternative splicing of tau in frontotemporal dementia and Parkinsonism linked to chromosome 17. J. Biol. Chem. 276: 42986-49293.
82. Kan, J.L. and Green, M.R. 1999. Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. Genes & Dev. 13: 462-471.
83. Kiesewetter, S., Macek Jr., M., Davis, C., Curristin, S.M., Chu, C.S., Graham, C., Shrimpton, A.E., Cashman, S.M., Tsui, L.C., Mickle, J., et al. 1993. A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat. Genet. 5: 274-278.
84. Kohsaka, T., Tagawa, M., Takekoshi, Y., Yanagisawa, H., Tadokoro, K., and Yamada, M. 1999. Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome. Hum. Mutat, 14: 466-470.
85. Korenbrot, J.I. and Fernald, R.D. 1989. Circadian rhythm and light regulate opsin mRNA in rod photoreceptors. Nature 337: 454-457.
86. Krawczak, M., Reiss, J., and Cooper, D.N. 1992. The mutational spectrum of single base-pair substitutions in messenger RNA splice junctions of human genes-Causes and consequences. Hum. Genet. 90: 41-54.
87. Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. 1993. WT-1 is required for early kidney development. Cell 74: 679-691.
88. Ladd, A.N. and Cooper, T.A. 2002. Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol. 3: 8.1-8.16.
89. Ladd, A.N., Charlet-B., N., and Cooper, T.A. 2001. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol. Cell. Biol. 21: 1285-1296.
90. Lallena, M.J., Chalmers, K.J., Llamazares, S., Lamond, A.I., and Valcarcel, J. 2002. Splicing regulation at the second catalytic step by Sex-lethal involves 3′ splice site recognition by SPF45. Cell 109: 285-296.
91. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., et al. 2001. Initial sequencing and analysis of the human genome. Nature 409: 860-921.
92. Larriba, S., Bassas, L., Gimenez, J., Ramos, M.D., Segura, A., Nunes, V., Estivill, X., and Casals, T. 1998. Testicular CFTR splice variants in patients with congenital absence of the vas deferens. Hum. Mol. Genet. 7: 1739-1743.
93. Larsson, S.H., Charlieu, J.P., Miyagawa, K., Engelkamp, D., Rassoulzadegan, M., Ross, A., Cuzin, F., Vanheyningen, V., and Hastie, N.D. 1995. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81: 391-401.
94. Lecomte, C.M., Renard, A., and Martial, J.A. 1987. A new natural hGH variant - 17.5 kD - produced by alternative splicing. An additional consensus sequence which might play a role in branchpoint selection. Nucleic Acids Res. 15: 6331-6348.
95. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., and Melki, J. 1997. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16: 265-269.
96. Lim, L.P. and Burge, C.B. 2001. A computational analysis of sequence features involved in recognition of short introns. Proc. Natl. Acad. Sci. 98: 11193-11198.
97. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W., and Ranum, L.P. 2001. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864-867.
98. Liu, H.X., Zhang, M., and Krainer, A.R. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes & Dev. 12: 1998-2012.
99. Liu, H.X., Chew, S.L., Cartegni, L., Zhang, M.Q., and Krainer, A.R. 2000. Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol. Cell. Biol. 20: 1063-1071.
100. Liu, H.X., Cartegni, L., Zhang, M.Q., and Krainer, A.R. 2001. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet. 27: 55-58.
101. Liu, X., Jiang, Q., Mansfield, S.G., Puttaraju, M., Zhang, Y., Zhou, W., Cohn, J.A., Garcia-Blanco, M.A., Mitchell, L.G., and Engelhardt, J.F. 2002. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing. Nat. Biotechnol. 20: 47-52.
102. Liu, Z.R. 2002. p68 RNA helicase is an essential human splicing factor that acts at the U1 snRNA-5′ splice site duplex. Mol. Cell. Biol. 22: 5443-5450.
103. Lu, X., Timchenko, N.A., and Timchenko, L.T. 1999. Cardiac elav-type RNA-binding protein (ETR-3) binds to RNA CUG repeats expanded in myotonic dystrophy. Hum. Mol. Genet. 8: 53-60.
104. Luo, H.R., Moreau, G.A., Levin, N., and Moore, M.J. 1999. The human Prp8 protein is a component of both U2- and U12-dependent spliceosomes. RNA 5: 893-908.
105. Macgregor, P.F. and Squire, J.A. 2002. Application of microarrays to the analysis of gene expression in cancer. Clin. Chem. 48: 1170-1177.
106. Makarova, O.V., Makarov, E.M., Liu, S., Vornlocher, H.P., and Luhrmann, R. 2002. Protein 61K, encoded by a gene (PRPF31) linked to autosomal dominant retinitis pigmentosa, is required for U4/U6 · U5 tri-snRNP formation and pre-mRNA splicing. EMBO J. 21: 1148-1157.
107. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M., and Thornton, C.A. 2000. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1773.
108. Mankodi, A., Takahashi, M.P., Jiang, H., Beck, C.L., Bowers, W.J., Moxley, R.T., Cannon, S.C., and Thornton, C.A. 2002. Expanded CUG repeats trigger aberrant splicing of C1C-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol. Cell 10: 35-44.
109. Maquat, L.E. and Carmichael, G.G. 2001. Quality control of mRNA function. Cell 104:173-176.
110. McCarthy, E.M. and Phillips III, J.A. 1998. Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum. Mol. Genet. 7: 1491-1496.
111. McCullough, A.J. and Berget, S.M. 2000. An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5′ splice sites. Mol. Cell. Biol. 20: 9225-9235.
112. McKie, A.B., McHale, J.C., Keen, T.J., Tarttelin, E.E., Goliath, R., van Lith-Verhoeven, J.J., Greenberg, J., Ramesar, R.S., Hoyng, C.B., Cremers, F.P., et al. 2001. Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum. Mol. Genet. 10: 1555-1562.
113. Meister, G., Buhler, D., Pillai, R., Lottspeich, F., and Fischer, U. 2001. A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs. Nat. Cell Biol. 3: 945-949.
114. Melo, K.F., Martin, R.M., Costa, E.M., Carvalho, F.M., Jorge, A.A., Arnhold, I.J., and Mendonca, B.B. 2002. An unusual phenotype of Frasier syndrome due to IVS9 +4C → T mutation in the WT1 gene: Predominantly male ambiguous genitalia and absence of gonadal dysgenesis. J. Clin. Endocrinol. Metab. 87: 2500-2505.
115. Mercatante, D.R. and Kole, R. 2002. Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: Effects on gene expression. Biochim. Biophys. Acta 1587: 126-132.
116. Michalowski, S., Miller, J.W., Urbinati, C.R., Paliouras, M., Swanson, M.S., and Griffith, J. 1999. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res. 27: 3534-3542.
117. Miles, C., Elgar, G., Coles, E., Kleinjan, D.J., van Heyningen, V., and Hastie, N. 1998. Complete sequencing of the Fugu WAGR region from WT1 to PAX6: Dramatic compaction and conservation of synteny with human chromosome 11p13. Proc. Natl. Acad. Sci. 95: 13068-13072.
118. n expansions associated with myotonic dystrophy. EMBO J. 19: 4439-4448.
119. Modrek, B. and Lee, C. 2002. A genomic view of alternative splicing. Nat. Genet. 30: 13-19.
120. -/- mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9: 333-339.
121. Moseley, C.T., Mullis, P.E., Prince, M.A., and Phillips III, J.A. 2002. An exon splice enhancer mutation causes autosomal dominant GH deficiency. J. Clin. Endocrinol. Metab. 87: 847-852.
122. Nakai, K. and Sakamoto, H. 1994. Construction of a novel database containing aberrant splicing mutations of mammalian genes. Gene 141: 171-177.
123. Napieraa, M. and Krzyosiak, W.J. 1997. CUG repeats present in myotonin kinase RNA form metastable 'slippery' hairpins. J. Biol. Chem. 272: 31079-31085.
124. Niksic, M., Romano, M., Buratti, E., Pagani, F., and Baralle, F.E. 1999. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9. Hum. Mol. Genet. 8: 2339-2349.
125. Nissim-Rafinia, M. and Kerem, B. 2002. Splicing regulation as a potential genetic modifier. Trends Genet. 18: 123-127.
126. Nissim-Rafinia, M., Chiba-Falek, O., Sharon, G., Boss, A., and Kerem, B. 2000. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum. Mol. Genet. 9: 1771-1778.
127. Noone, P.G. and Knowles, M.R. 2001. 'CFTR-opathies': Disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir. Res. 2: 328-332.
128. Noone, P.G., Pue, C.A., Zhou, Z., Friedman, K.J., Wakeling, E.L., Ganeshananthan, M., Simon, R.H., Silverman, L.M., and Knowles, M.R. 2000. Lung disease associated with the IVS8 5T allele of the CFTR gene. Am. J. Respir. Crit. Care Med. 162: 1919-1924.
129. Nussinov, R. 1988. Conserved quartets near 5′ intron junctions in primate nuclear pre-mRNA. J. Theor. Biol. 133: 73-84.
130. + gene encodes an essential protein with homology to c-Myb. EMBO J. 13: 471-483.
131. Owen, N., Doe, C.L., Mellor, J., and Davies, K.E. 2000. Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein. Hum. Mol. Genet. 9: 675-684.
132. Pagani, F., Buratti, E., Stuani, C., Romano, M., Zuccato, E., Niksic, M., Giglio, L., Faraguna, D., and Baralle, F.E. 2000. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J. Biol. Chem. 275: 21041-21047.
133. Pagani, F., Buratti, E., Stuani, C., Bendix, R., Dork, T., and Baralle, F.E. 2002. A new type of mutation causes a splicing defect in ATM. Nat. Genet. 30: 426-429.
134. Pellizzoni, L., Kataoka, N., Charroux, B., and Dreyfuss, G. 1998. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95: 615-624.
135. Pellizzoni, L., Yong, J., and Dreyfuss, G. 2002. Essential role for the SMN complex in the specificity of snRNP assembly. Science 298: 1775-1779.
136. Philips, A.V. and Cooper, T.A. 2000. RNA processing and human disease. Cell Mol. Life Sci. 57: 235-249.
137. Philips, A.V., Timchenko, L.T., and Cooper, T.A. 1998. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741.
138. Pilch, B., Allemand, E., Facompre, M., Bailly, C., Riou, J.F., Soret, J., and Tazi, J. 2001. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 61: 6876-6884.
139. Proudfoot, N.J., Furger, A., and Dye, M.J. 2002. Integrating mRNA processing with transcription. Cell 108: 501-512.
140. Raker, V.A., Plessel, G., and Luhrmann, R. 1996. The snRNP core assembly pathway: Identification of stable core protein heteromeric complexes and an snRNP subcore particle in vitro. EMBO J. 15: 2256-2269.
141. Reed, R. 1996. Initial splice-site recognition and pairing during pre-mRNA splicing. Curr. Opin. Gen. Dev. 6: 215-220.
142. n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc. Natl. Acad. Sci. 94: 13221-13226.
143. Rogan, P.K., Faux, B.M., and Schneider, T.D. 1998. Information analysis of human splice site mutations. Hum. Mutat. 12: 153-171.
144. Savkur, R.S., Philips, A.V., and Cooper, T.A. 2001. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet. 29: 40-47.
145. Schrank, B., Gotz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G., and Sendtner, M. 1997. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. 94: 9920-9925.
146. Seznec, H., Agbulut, O., Sergeant, N., Savouret, C., Ghestem, A., Tabti, N., Willer, J.C., Ourth, L., Duros, C., Brisson, E., et al. 2001. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet. 10: 2717-2226.
147. Sirand-Pugnet, P., Durosay, P., Brody, E., and Marie, J. 1995. An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken β-tropomyosin pre-mRNA. Nucleic Acids Res. 23: 3501-3507.
148. Slaugenhaupt, S.A., Blumenfeld, A., Gill, S.P., Leyne, M., Mull, J., Cuajungco, M.P., Liebert, C.B., Chadwick, B., Idelson, M., Reznik, L., et al. 2001. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am. J. Hum. Genet. 68: 598-605.
149. Smith, C.W. and Valcarcel, J. 2000. Alternative pre-mRNA splicing: The logic of combinatorial control. Trends Biochem. Sci. 25: 381-388.
150. Sneath, R.J. and Mangham, D.C. 1998. The normal structure and function of CD44 and its role in neoplasia. Mol. Pathol. 51:191-200.
151. Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., and Ghetti, B. 1998. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. 95: 7737-7741.
152. Stickeler, E., Kittrell, F., Medina, D., and Berget, S.M. 1999. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582.
153. Stickeler, E., Fraser, S.D., Honig, A., Chen, A.L., Berget, S.M., and Cooper, T.A. 2001. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. EMBO J. 20: 3821-3830.
154. Strong, T.V., Wilkinson, D.J., Mansoura, M.K., Devor, D.C., Henze, K., Yang, Y.P., Wilson, J.M., Cohn, J.A., Dawson, D.C., Frizzell, R.A., et al. 1993. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum. Mol. Genet. 2: 225-230.
155. Sun, H. and Chasin, L.A. 2000. Multiple splicing defects in an intronic false exon. Mol. Cell. Biol. 20: 6414-6425.
156. Tacke, R., Chen, Y., and Manley, J.L. 1997. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: Creation of an SRp40-specific splicing enhancer. Proc. Natl. Acad. Sci. 94: 1148-1153.
157. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D., and Singer, R.H. 1995. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol. 128: 995-1002.
158. Tam, W.Y. and Steitz, J.A. 1997. Pre-mRNA splicing: The discovery of a new spliceosome doubles the challenge. Trends Biochem. Sci. 22: 132-137.
159. Teigelkamp, S., Newman, A.J., and Beggs, J.D. 1995. Extensive interactions of PRP8 protein with the 5′ and 3′ splice sites during splicing suggest a role in stabilization of exon alignment by U5 snRNA. EMBO J. 14: 2602-2612.
160. Terns, M.P. and Terns, R.M. 2001. Macromolecular complexes: SMN - the master assembler. Curr. Biol. 11: R862-R864.
161. Tian, B., White, R.J., Xia, T., Welle, S., Turner, D.H., Mathews, M.B., and Thornton, C.A. 2000. Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA 6: 79-87.
162. n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res. 24: 4407-4414.
163. Timchenko, N.A., Cai, Z.J., Welm, A.L., Reddy, S., Ashizawa, T., and Timchenko, L.T. 2001. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J. Biol. Chem. 276: 7820-7826.
164. Varani, L., Spillantini, M.G., Goedert, M., and Varani, G. 2000. Structural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics. Nucleic Acids Res. 28: 710-719.
165. Vervoort, R., Lennon, A., Bird, A.C., Tulloch, B., Axton, R., Miano, M.G., Meindl, A., Meitinger, T., Ciccodicola, A., and Wright, A.F. 2000. Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nat. Genet. 25: 462-466.
166. Vidal, V.P., Verdone, L., Mayes, A.E., and Beggs, J.D. 1999. Characterization of U6 snRNA-protein interactions. RNA 5: 1470-1481.
167. 2+-dependent chemistry at the catalytic core? Cell 109: 149-152.
168. Vithana, E.N., Abu-Safieh, L., Allen, M.J., Carey, A., Papaioannou, M., Chakarova, C., Al-Maghtheh, M., Ebenezer, N.D., Willis, C., Moore, A.T., et al. 2001. A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol. Cell 8: 375-381.
169. Wang, A., Forman-Kay, J., Luo, Y., Luo, M., Chow, Y.H., Plumb, J., Friesen, J.D., Tsui, L.C., Heng, H.H., Woolford Jr., J.L., et al. 1997. Identification and characterization of human genes encoding Hprp3p and Hprp4p, interacting components of the spliceosome. Hum. Mol. Genet. 6: 2117-2126.
170. Wang, H.Y., Xu, X., Ding, J.H., Bermingham Jr., J.R., and Fu, X.D. 2001. SC35 plays a role in T cell development and alternative splicing of CD45. Mol. Cell 7: 331-342.
171. Wang, J. and Dreyfuss, G. 2001. A cell system with targeted disruption of the SMN gene: Functional conservation of the SMN protein and dependence of Gemin2 on SMN. J. Biol. Chem. 276: 9599-9605.
172. Wang, J., Pegoraro, E., Menegazzo, E., Gennarelli, M., Hoop, R.C., Angelini, C., and Hoffman, E.P. 1995. Myotonic dystrophy: Evidence for a possible dominant-negative RNA mutation. Hum. Mol. Genet. 4: 599-606.
173. Weidenhammer, E.M., Singh, M., Ruiz-Noriega, M., and Woolford Jr., J.L. 1996. The PRP31 gene encodes a novel protein required for pre-mRNA splicing in Saccharomyces cerevisiae. Nucleic Acids Res. 24: 1164-1170.
174. Wilhelm, D. and Englert, C. 2002. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes & Dev. 16: 1839-1851.
175. Will, C.L. and Luhrmann, R. 2001. Spliceosomal UsnRNP biogenesis, structure and function. Curr. Opin. Cell Biol. 13: 290-301.
176. Wirth, B. 2000. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat. 15: 228-237.
177. Wu, J.I., Reed, R.B., Grabowski, P.J., and Artzt, K. 2002. Function of quaking in myelination: Regulation of alternative splicing. Proc. Natl. Acad. Sci. 99: 4233-4238.
178. Wyatt, J.R., Sontheimer, E.J., and Steitz, J.A. 1992. Site-specific cross-linking of mammalian U5 snRNP to the 5′ splice site before the first step of pre-mRNA splicing. Genes & Dev. 6: 2542-2553.
179. Xiao, S.H. and Manley, J.L. 1997. Phosphorylation of the ASF/ SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes & Dev. 11: 334-344.
180. Yamaguchi, F., Saya, H., Bruner, J.M., and Morrison, R.S. 1994. Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc. Natl. Acad. Sci. 91: 484-488.
181. Yeakley, J.M., Fan, J.B., Doucet, D., Luo, L., Wickham, E., Ye, Z., Chee, M.S., and Fu, X.D. 2002. Profiling alternative splicing on fiber-optic arrays. Nat. Biotechnol. 20: 353-358.
182. Zhou, Z., Licklider, L.J., Gygi, S.P., and Reed, R. 2002. Comprehensive proteomic analysis of the human spliceosome. Nature 419: 182-185.
183. Zhu, J., Mayeda, A., and Krainer, A.R. 2001. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Mol. Cell 8: 1351-1361.